Jayasree K. Iyer

Jayasree K. Iyer is the executive director of the Access to Medicine Foundation

  • Aedes sp. Mosquitoes are active during the daytime, show aggressive human-biting behavior, and prefer to live near people and animals to bite. Mosquitoes need blood to produce eggs. After feeding, female mosquitoes look for water sources to lay eggs. The Aedes mosquito is a known vector of several viruses including yellow fever virus, dengue virus, chikungunya virus, and Zika virus. Aedes mosquitoes begin their blood meal from the human body in a forest at Tehatta, West Bengal; India on 18/05/2023. (Photo by Soumyabrata Roy/NurPhoto via Getty Images)Commentary

    Climate change is unleashing a tsunami of infectious diseases–and we have fewer and fewer drugs that can treat them

    By
  • A workers delivers oxygen tanks to a medical store in Bamabang district, Metro Manila, the Philippines, on Wednesday, Sept. 1, 2021. Last week the Philippines extended virus restrictions in the capital region until Sept. 7 as the government tries to balance the need to contain the pandemic with boosting the economy. Photographer: Veejay Villafranca/Bloomberg via Getty ImagesCommentary

    With COVID patients gasping for breath, it’s time to close the oxygen gap

    By
  • People wearing protective masks wait in line to refill oxygen bottles in Lima, Peru, on Wednesday, Feb. 10, 2021. Peru has reported more than 42,000 confirmed deaths from Covid-19, and a spike in coronavirus infections since December has led to deficits of medicinal oxygen and a shortage of intensive care unit beds and medical staff. Photographer: Miguel Yovera/Bloomberg via Getty ImagesCommentary

    Gasping for breath: COVID-19 has exposed the world’s medical oxygen crisis

    By
  • SWITZERLAND-ECONOMY-POLITICS-DIPLOMACY GlaxoSmithKline CEO Sir Andrew Witty is pictured during a session of the World Economic Forum, on January 19, 2017 in Davos. / AFP / FABRICE COFFRINI (Photo credit should read FABRICE COFFRINI/AFP via Getty Images)Commentary

    Big Pharma’s new CEOs must step up to erase inequities in drug access

    By